Drug Shortage Report for XERESE

Last updated on 2023-04-11 History
Report ID 183894
Drug Identification Number 02404044
Brand name XERESE
Common or Proper name XERESE
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) HYDROCORTISONE ACYCLOVIR
Strength(s) 1% 5%
Dosage form(s) CREAM
Route of administration TOPICAL TOPICAL
Packaging size 5g
ATC code D06BB
ATC description CHEMOTHERAPEUTICS FOR TOPICAL USE
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date 2023-04-21
Actual start date
Estimated end date 2023-06-13
Actual end date 2023-04-07
Shortage status Avoided shortage
Updated date 2023-04-11
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2023-04-11 French Compare
v3 2023-04-11 English Compare
v2 2023-02-08 French Compare
v1 2023-02-08 English Compare

Showing 1 to 4 of 4